Golden Valley Development, Inc. (the “Company”), a developer and marketer of patented and patentable technologies, is pleased to announce a purchase order agreement and strategic partnership with Mel-Mont Medical, LLC, (“Mel-Mont”) to commercialize XytoTest(TM) worldwide. (www.xytotest.com). The cervical cancer diagnostic test market will reach $9 billion by 2020 with an annual growth rate (CAGR) of 6.1%, according to Transparency Market Research. Over half a million cases are detected every year. Over 275,000 women die every year from cervical cancer, ofRead more
- Research on Lodonal for HIV related GI complications featured in Plus Magazine
- Cannabis Strategic Ventures and Sunniva Inc. Enter Into Cannabis Extraction Services Agreement
- Precision Therapeutics Merger with Helomics Corp. Accelerates Personalized Cancer Treatment Strategies
- Precision Therapeutics Granted European Patent for its Automated, Direct-to-Drain Medical Fluid Disposal System
- PHI Group Partners with Fintech Green Investment Company
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More